Amicus Therapeutics Inc. buy Morgan Stanley
Start price
10.05.24
/
50%
€8.60
Target price
10.05.25
€17.64
Performance (%)
6.40%
Price
20.06.24
€9.15
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 6.40%. This prediction currently runs until 10.05.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -7.107% | -7.107% |
iShares Core DAX® | -0.315% | -2.776% |
iShares Nasdaq 100 | 1.250% | 7.480% |
iShares Nikkei 225® | -1.284% | -2.199% |
iShares S&P 500 | 1.141% | 4.717% |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Morgan Stanley from $20.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
19.12.23
19.12.23
€18.24
19.12.24
19.12.24
-23.75%
20.06.24
20.06.24